ATE501724T1 - Lektinzusammensetzung zur prophylaxe und/oder behandlung von unerwünschten arzneimittelnebenwirkungen - Google Patents

Lektinzusammensetzung zur prophylaxe und/oder behandlung von unerwünschten arzneimittelnebenwirkungen

Info

Publication number
ATE501724T1
ATE501724T1 AT09162527T AT09162527T ATE501724T1 AT E501724 T1 ATE501724 T1 AT E501724T1 AT 09162527 T AT09162527 T AT 09162527T AT 09162527 T AT09162527 T AT 09162527T AT E501724 T1 ATE501724 T1 AT E501724T1
Authority
AT
Austria
Prior art keywords
side effects
composition
prophylaxis
treatment
adverse drug
Prior art date
Application number
AT09162527T
Other languages
English (en)
Original Assignee
Helvista Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helvista Ag filed Critical Helvista Ag
Application granted granted Critical
Publication of ATE501724T1 publication Critical patent/ATE501724T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
AT09162527T 2009-02-10 2009-06-11 Lektinzusammensetzung zur prophylaxe und/oder behandlung von unerwünschten arzneimittelnebenwirkungen ATE501724T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102009008313 2009-02-10

Publications (1)

Publication Number Publication Date
ATE501724T1 true ATE501724T1 (de) 2011-04-15

Family

ID=41259986

Family Applications (1)

Application Number Title Priority Date Filing Date
AT09162527T ATE501724T1 (de) 2009-02-10 2009-06-11 Lektinzusammensetzung zur prophylaxe und/oder behandlung von unerwünschten arzneimittelnebenwirkungen

Country Status (3)

Country Link
EP (1) EP2218456B1 (de)
AT (1) ATE501724T1 (de)
DE (2) DE202009017877U1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102010033458B4 (de) 2010-08-05 2016-03-10 Helvista Ag Emulgierte Lektinzusammensetzungen und ihre Verwendung
EP3978006B1 (de) 2020-10-02 2025-11-05 YACARE GmbH Zusammensetzung mit optimiertem lektingehalt und ihre verwendung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4889842A (en) 1987-03-03 1989-12-26 Morris Randall E Concanavalin A dimers as therapeutic agents
GB9718413D0 (en) * 1997-08-29 1997-11-05 Alizyme Therapeutics Ltd Compositions
GB9613070D0 (en) * 1996-06-21 1996-08-28 Rowett Research Services Limit Dietary lectins
DE10321725A1 (de) 2003-05-14 2004-12-02 Mucos Pharma Gmbh & Co Enzymhaltige Zusammensetzungen, daraus hergestellte diätetische Lebensmittel und Arzneimittel und ihre Verwendung für medizinische Zwecke
ATE539622T1 (de) * 2008-04-02 2012-01-15 Helvista Ag Verwendung einer zusammensetzung, welche ein pflanzenlektin, ein proteolytisches enzym und eine selenverbindung umfasst, zum schleimhautschutz und zur linderung anderer symptome bei krebspatienten

Also Published As

Publication number Publication date
EP2218456B1 (de) 2011-03-16
DE202009017877U1 (de) 2010-08-05
EP2218456A1 (de) 2010-08-18
DE502009000459D1 (de) 2011-04-28

Similar Documents

Publication Publication Date Title
MX2025000380A (es) Metodos de tratamiento con farmacos del sustrato cyp3a4
AR065033A1 (es) Metodos para prevenir y tratar trastornos neurodegenerativos
DK1970059T3 (da) Lægemiddel med calciumdobesilat til behandling og profylakse af senelidelser
MX2022003072A (es) Uso de pridopidina para el tratamiento de la disminucion funcional.
ATE551063T1 (de) Verwendung von bifidobacterium longum zur prophylaxe und behandlung von entzündungen
WO2014121298A3 (en) Methods of populating a gastrointestinal tract
MX2016006221A (es) Composiciones para usar en la prevencion o tratamiento de la enterocolitis necrotizante en infantes y niños pequeños.
TN2011000416A1 (en) Pharmaceutical composition comprising glucopyranosyl diphenylmethane derivatives, pharmaceutical dosage form thereof, process for their preparation and uses thereof for improved glycemic control in a patient
MY153062A (en) Methods of treating gastrointestinal disorders independent of the intake of food
MX2023005014A (es) Metodos de tratamiento de enfermedades inflamatorias cronicas.
MX2010009270A (es) Compuestos y metodos para la prevencion o tratamiento de reestenosis.
PH12013500857A1 (en) Methods and compositions for treating hiv-associated diarrhea
MY187167A (en) Medical treatments based on anamorelin
NZ754706A (en) Use of lactic acid bacteria to treat or prevent gestational diabetes mellitus
EA201200428A1 (ru) Композиция и способ для лечения ожирения
BR112016029437A2 (pt) métodos para tratamento e prevenção de doenças de instabilidade vascular
MX2015005733A (es) Compuestos triciclicos para usarse en el tratamiento y/o control de obesidad.
ATE501724T1 (de) Lektinzusammensetzung zur prophylaxe und/oder behandlung von unerwünschten arzneimittelnebenwirkungen
HRP20151320T1 (hr) Kompozicija päśelinjeg meda i l-alanil-l-glutamina
MX2020001217A (es) Metodos de tratamiento de sintomas de gastroparesia usando velusetrag.
BR112015020566A2 (pt) moduladres de ror gama
EP4289438C0 (de) Zusammensetzung zur prävention, linderung oder behandlung von schlafstörungen mit darmmikrobiota oder extrazellulären vesikeln als wirkstoff daraus
MX2023006765A (es) Metodo para proporcionar terapia de celiprolol a un paciente.
MD10Z (ro) Metodă de tratament al pielonefritei gestaţionale
EA201990553A1 (ru) Применение придопидина для лечения ухудшения функциональной способности